Open access · US-GOV via ClinicalTrials.gov Clinical trial

The Relationship Between Sarcopenia and Cardiovascular Disease in Chronic Kidney Disease Stage 3 or Higher and the Risk Involved.

Authors not listed

Shanghai Jiao Tong University School of Medicine · 2020

Dysbiosis Human Randomized controlled trial

Abstract

This study explores the risk factors for sarcopenia in patients with chronic kidney disease and the effects of sarcopenia on cardiovascular disease. Treatment of sarcopenia and cardiovascular complications provides a basis for improving the quality of life and survival of patients with chronic kidney disease.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-25 MST

Cite this

APA

Anonymous. (2020). The Relationship Between Sarcopenia and Cardiovascular Disease in Chronic Kidney Disease Stage 3 or Higher and the Risk Involved. <em>Shanghai Jiao Tong University School of Medicine</em>. https://clinicaltrials.gov/study/NCT05479331

Vancouver

Anonymous. The Relationship Between Sarcopenia and Cardiovascular Disease in Chronic Kidney Disease Stage 3 or Higher and the Risk Involved. Shanghai Jiao Tong University School of Medicine. 2020.

BibTeX

@misc{anon2020TheRel, title = {The Relationship Between Sarcopenia and Cardiovascular Disease in Chronic Kidney Disease Stage 3 or Higher and the Risk Involved.}, author = {Anonymous}, journal = {Shanghai Jiao Tong University School of Medicine}, year = {2020}, }